Evidence map›Paper›PMID 30997666›Full record

ArticleMolecular biotechnology2019

Optimizing Periplasmic Expression in Escherichia coli for the Production of Recombinant Proteins Tagged with the Small Metal-Binding Protein SmbP.

Bryan D Santos, Jose Ruben Morones-Ramirez, Isaias Balderas-Renteria, Nestor G Casillas-Vega, David W Galbraith, Xristo Zarate

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Bryan D SantosUniversidad Autonoma de Nuevo Leon, Facultad de Ciencias Quimicas, 66455, San Nicolas de los Garza, NL, Mexico.
Jose Ruben Morones-RamirezUniversidad Autonoma de Nuevo Leon, Facultad de Ciencias Quimicas, 66455, San Nicolas de los Garza, NL, Mexico.
Isaias Balderas-RenteriaUniversidad Autonoma de Nuevo Leon, Facultad de Ciencias Quimicas, 66455, San Nicolas de los Garza, NL, Mexico.
Nestor G Casillas-VegaDepartamento de Patologia Clinica, Universidad Autonoma de Nuevo Leon, Hospital Universitario Dr. Jose Eleuterio Gonzalez, 64460, Monterrey, NL, Mexico.
David W GalbraithSchool of Plant Sciences and BIO5 Institute, University of Arizona, Tucson, AZ, 85721, USA.
Xristo ZarateUniversidad Autonoma de Nuevo Leon, Facultad de Ciencias Quimicas, 66455, San Nicolas de los Garza, NL, Mexico. xristo.zaratekl@uanl.edu.mx.ORCID http://orcid.org/0000-0002-9824-3961
Universidad Autónoma de Nuevo León · MXUniversity of Arizona · US

Funding

CONACYT CB 2012-179774-BUANL-PAICYT-2015 CN567-15
6 · The paper itself

Abstract

We have previously shown that the small metal-binding protein (SmbP) extracted from the gram-negative bacterium Nitrosomonas europaea can be employed as a fusion protein for the expression and purification of recombinant proteins in Escherichia coli. With the goal of increasing the amounts of SmbP-tagged proteins produced in the E. coli periplasm, we replaced the native SmbP signal peptide with three different signal sequences: two were from the proteins CusF and PelB, for transport via the Sec pathway, and one was the signal peptide from TorA, for transport via the Tat pathway. Expression of SmbP-tagged Red Fluorescent Protein (RFP) using these three alternative signal peptides individually showed a considerable increase in protein levels in the periplasm of E. coli as compared to its level using the SmbP signal sequence. Therefore, for routine periplasmic expression and purification of recombinant proteins in E. coli, we highly recommend the use of the fusion proteins PelB-SmbP or CusF-SmbP, since these signal sequences increase periplasmic production considerably as compared to the wild-type. Our work, finally, demonstrates that periplasmic expression for SmbP-tagged proteins is not limited to the Sec pathway, in that the TorA-SmbP construct can export reasonable quantities of folded proteins to the periplasm. Although the Sec route has been the most widely used, sometimes, depending on the nature of the protein of interest, for example, if it contains cofactors, it is more appropriate to consider using the Tat route over the Sec. SmbP therefore can be recommended in terms of its particular versatility when combined with signal peptides for the two different routes.

Indexed as

Bacterial ProteinsCarrier ProteinsCation Transport ProteinsCloning, MolecularCopper Transport ProteinsEscherichia coliEscherichia coli ProteinsGene ExpressionGenes, ReporterGenetic VectorsIron-Binding ProteinsLuminescent ProteinsNitrosomonas europaeaOxidoreductases, N-DemethylatingPeriplasmPolysaccharide-LyasesBacterial ProteinsCarrier ProteinsCation Transport Proteinscopper-binding proteinCopper Transport ProteinsCusF protein, E coliEscherichia coli ProteinsIron-Binding ProteinsLuminescent ProteinsOxidoreductases, N-Demethylatingpectate lyasePolysaccharide-LyasesProtein Sorting SignalsRecombinant Fusion ProteinsRed Fluorescent Proteintrimethylamine dehydrogenasezinc-binding proteinCusFGFPIMACPelBPeriplasmProtein expression and purificationRFPSec pathwaySignal sequenceSmbPTat pathwayTorA

Identifiers

PMID30997666
OpenAlexW2937667886

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.